Actavis to acquire pharmaceutical company Durata Therapeutics

The U.S. Federal Trade Commission has cleared the Actavis proposal to acquire pharmaceutical company Durata Therapeutics, according to a PBRHome report.

Advertisement

Actavis has a broad pharmaceuticals portfolio in areas including gastroenterology, women’s health, urology and more. The company operates more than 30  manufacturing and distribution facilities.

More articles on gastroenterology:
5 must-reads for the forward-thinking gastroenterology leader
Dr. Lawrence Kosinski: 4 thoughts on the future of gastroenterology
EndoChoice considers $100M+ IPO

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.